Filter & sort
The latest funding rounds from the UK tech ecosystem. Updated 28 August 2026.
Announcements
6,191
Total raised
£161B
disclosed amounts
This month
£621M
raised so far
Foresight has taken a minority equity position in the business through its venture capital trusts.
"The goal of Spektrix is to empower arts and entertainment organisations with the tools they need to excel in the evolving arts economy. This injection of growth capital gives us additional resources to expand strategically, increase the pace of innovation, and fully realise our ambitions for the sector on both sides of the Atlantic."
The investment from the Development Bank of Wales and regional angels will fund platform development and customer acquisition.
"We are delighted to secure Development Bank of Wales as an investor. This investment will be used to develop our technology platform and recruit more customers to our service."
J.P. Morgan has taken a minority equity stake in the workplace pensions provider as part of a strategic placement round.
"We are delighted to have secured this investment from J.P. Morgan, as it signifies a positive step in our growth and international reach. From the outset our objective has been to put user engagement and experience at the heart of everything we do, utilising technology to build an unrivalled platform. Our journey has just started, the opportunities to disrupt and do things differently in this sector are staggering, and we will be leading the way."
NVM Private Equity backs the London-based employee engagement platform with growth capital.
"This is a really exciting deal for NVM. We were impressed from the outset by the clear vision Luke has for the business and the traction he has achieved over the last few years; it’s exactly the type of early-stage business we look to support. Organisations are placing more and more focus on employee engagement and we believe there is great potential for Mo to work alongside them to improve their culture."
The funding will support the implementation of specialised screening technology aimed at identifying rare diseases earlier in the patient journey.
"We are delighted to support Mendelian as part of our work into rare diseases. With over 3 million rare disease patients in the UK, innovative technologies using data analytics and machine learning like this are increasingly vital in ensuring that these conditions are diagnosed earlier to provide more targeted and personalised treatment for patients."
